Back to Results
First PageMeta Content
Biotechnology / Recombinant DNA / Kommanditgesellschaft auf Aktien / Pharmaceutical industry / Technology / Merck / Ventria Bioscience / Merck KGaA


Dear Ventria Shareholders: Today, Ventria and Merck KGaA announced an exclusive collaboration. Ventria will supply a recombinant protein made using the ExpressTec system to the EMD Millipore Division of Merck KGaA based
Add to Reading List

Document Date: 2012-03-26 11:48:40

Open Document

File Size: 130,90 KB

Share Result on Facebook

City

San Francisco / Darmstadt / /

Company

Merck KGaA / Scott E. Deeter / /

Country

Germany / /

Event

Person Communication and Meetings / FDA Phase / /

IndustryTerm

manufacturing methods / /

MedicalCondition

antibiotic associated diarrhea / /

Organization

Society of Toxicology / /

Person

Ventria Bioscience / /

/

Position

President & CEO / /

Product

Ven100 / /

ProvinceOrState

Kansas / /

Technology

biomanufacturing / /

URL

www.Ventria.com / http /

SocialTag